A Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing Enterocolitis - The Connection Study
A Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing Enterocolitis - The Connection Study
IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.
Inclusion Criteria:
Exclusion Criteria:
Hartford, Connecticut 06106, United States
Springfield, Illinois 62769, United States
Boston, Massachusetts 02215, United States
Valhalla, New York 10595, United States
Austin, Texas 78705, United States
Pleven, Bulgaria
Sofia, Bulgaria
Szczecin, Poland
Szczecin, Poland